Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. scholar.google.com › citations‪Sarah de Ferranti‬ - ‪Google Scholar‬

    2011. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. S de Ferranti, D Mozaffarian. Clinical chemistry 54 (6), 945-955. , 2008. 997. 2008. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

  2. www.childrenshospital.org › directory › sarah-deferrantiSarah deFerranti, MD, MPH | Boston Children's Hospital

    Sarah deFerranti. MD, MPH. Chief, Division of Ambulatory Cardiology; Senior Associate Cardiologist, Department of Cardiology. Associate Professor of Pediatrics, Harvard Medical School. Request an Appointment View Research Profile. Phone: 617-355-2079. Fax: 617-730-0600. Email: Email Me. NPI: 1528059474. Print Profile.

  3. Imagens

    • Genetically inherited high cholesterol twice as common as believed ...
    • Is Your Child At Risk For Heart Disease?
    • SARAH DE FERRANTI DR DIRECTOR PREVENTIVE Editorial Stock Photo - Stock ...
    • SARAH DE FERRANTI DR DIRECTOR PREVENTIVE Editorial Stock Photo - Stock ...
    • Dr. Sarah De Ferranti, MD – Boston, MA | Pediatric Cardiology

    Ver tudo

  4. www.childrenshospital.org › sarah-deferrantiSarah Deferranti | Researchers | Boston Children's Hospital

    Research Directory. Researcher. Sarah deFerranti. MD, MPH. Associate Professor of Pediatrics, Harvard Medical School. View Clinician Profile. Phone: 617-355-2079. Fax: 617-730-0600. Email: sarah.deferranti@childrens.harvard.edu. NPI: 1528059474. Print Profile. Media. Publications. Contact Us. Media. Caregiver Profile. Meet Dr. Sarah de Ferranti.

  5. www.ahajournals.org › doi › pdfCardiovascular Risk Reduction in High-Risk Pediatric Patients

    22 de mar. de 2019 · Sarah D. de Ferranti, MD, MPH, FAHA, Chair Julia Steinberger, MD, MS, FAHA, Co-Chair Rebecca Ameduri, MD Annette Baker, RN, MSN, CPNP Holly Gooding, MD, MSc Aaron S. Kelly, PhD, FAHA Michele Mietus-Snyder, MD Mark M. Mitsnefes, MD, MS Amy L. Peterson, MD Julie St-Pierre, MD, PhD, FAHA Elaine M. Urbina, MD, MS, FAHA Justin P ...

  6. pubmed.ncbi.nlm.nih.gov › 30798614Cardiovascular Risk Reduction in High-Risk Pediatric Patients ...

    26 de mar. de 2019 · Abstract. This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis.

    • Sarah D de Ferranti, Julia Steinberger, Rebecca Ameduri, Annette Baker, Holly Gooding, Aaron S Kelly...
    • 2019

  7. connects.catalyst.harvard.edu › Profiles › profileSarah De Ferranti | Harvard Catalyst Profiles | Harvard Catalyst

    NIH. Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches. Role: Co-Principal Investigator. K23HL085308 (DE FERRANTI, SARAH D) Sep 1, 2007 - May 31, 2012. NIH. Nutritional Treatment of Overweight Adolescents with Cardiovascular Risk Factors. Role: Principal Investigator.

  8. www.cardiometabolichealth.org › faculty › sarah-ferrantiSarah de Ferranti | Cardiometabolic Health Congress

    About. Dr. de Ferranti is interested in describing, identifying, and evaluating and treating atherosclerotic risk factors during childhood to reduce cardiovascular disease burden during adulthood. She divides her time between clinical and implementation research, directing the Preventive Cardiology Clinic and providing clinical care for both ...